Nitrofurantoin Oral Capsule 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Nitrofurantoin: Oral capsule (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_15093.JPG
Nitrofurantoin 100mg Cap
Alvogen, Inc
Pill Identification: MACRODANTIN 100 mg 52427-288 
Drug Image file DrugItem_8743.JPG
Nitrofurantoin 100mg Cap
Teva Pharmaceuticals USA Inc
Pill Identification: Z 100 mg 2131,Zenith 100mg 2131 
Drug Image file DrugItem_8743.JPG
Nitrofurantoin 100mg Cap
Teva Pharmaceuticals USA Inc
Pill Identification: Z 100 mg 2131,Zenith 100mg 2131 
Drug Image file DrugItem_8743.JPG
Nitrofurantoin 100mg Cap
Teva Pharmaceuticals USA Inc
Pill Identification: Z 100 mg 2131,Zenith 100mg 2131 
Drug Image file DrugItem_20492.JPG
Nitrofurantoin 100mg Cap
Mylan Pharmaceuticals Inc
Pill Identification: MYLAN 1700 MYLAN 1700 

What is this Medicine?

NITROFURANTOIN (nye troe fyoor AN toyn) is an antibiotic. It is used to treat urinary tract infections.

CVS Pharmacy Patient Statistics for Nitrofurantoin: Oral capsule(100mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Nitrofurantoin (Macrocrystalline) 100mg Capsule

NDC: 477810308
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Urinary Tract Infection (UTI) Prophylaxis, Cystitis, Urinary Tract Infection (UTI)

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Nitrofurantoin (Macrocrystalline) 100mg Capsule
Drug Image file DrugItem_15093.JPG
Alvogen, Inc
Pill Identification: MACRODANTIN 100 mg 52427-288 
Shape: capsule
Color: yellow

Reported Side Effects for Nitrofurantoin (Macrocrystalline) 100mg Capsule

Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Cholestasis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Psychosis Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Confusion Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Cyanosis Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Death Of Liver Tissue Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Pseudotumor Cerebri Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Exfoliative Dermatitis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Depression Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Aplastic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Pulmonary Fibrosis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Lung Inflammation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Optic Nerve Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: DELAYED
No White Blood Cells Incidence:
1.0-5.0%*
Severity: SEVERE
Onset: DELAYED
Megaloblastic Anemia Incidence:
1.0-5.0%*
Severity: SEVERE
Onset: DELAYED
Hemolytic Anemia Incidence:
1.0-5.0%*
Severity: SEVERE
Onset: DELAYED
Low Platelet Count Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Nitrofurantoin

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.